Abstract: The present application discloses a clip-on earphone comprising: an earphone body having a first accommodating cavity, installed with a battery and a speaker; a clamping assembly comprising a first and a second clamping arm and an adjusting member. The first end of the first clamping arm is connected to the earphone body, and the second end to the second clamping arm via the adjusting member which adjusts a pivot angle between the first and second clamping arms to wear the earphone body onto an ear. The angle between the clamping assembly and the earphone body can be freely adjusted. Consumers can find a suitable wearing angle according to their own body and auricle shape, improving wearing experience and reducing pain caused by wearing earphones. By properly arranging earphone components, weight is concentrated on the earphone head to reduce pressure on ear side wall and improve wearing comfort.

Abstract: The present disclosure provides an information processing method, a terminal, and a non-transitory storage medium.

Abstract: A method includes receiving a record containing clinical information associated with a patient; and automatically processing the record using a multi-stage Artificial Intelligence (AI) engine to generate at least one suggested code for one or more portions of the clinical information; wherein the multi-stage AI engine comprises: a first module configured to identify content highlights within the one or more portions of the clinical information and associate the content highlights with candidate codes, respectively; and a second module configured to remove ones of the content highlights and/or ones of the candidate codes that have been identified and/or associated in error to generate corrected content highlights that are associated with the corrected candidate codes, respectively.

Abstract: A method includes receiving a record containing clinical information associated with a patient; processing the record using a first AI model that is trained based on medical term frequency throughout respective ones of a plurality of historical medical records; processing the record using a second AI model that is trained based on medical terms used in encounter portions of the respective ones of the plurality of historical medical records; generating a first recommendation for performing a coding review of the record based on processing the record using the first AI model; generating a second recommendation for performing the coding review of the record based on processing the record using the second AI model; and logically combining the first and second recommendation for performing the coding review to generate a final recommendation for performing the coding review.

Abstract: A method includes receiving a record containing first clinical information associated with a first patient; and automatically processing the record using a multi-stage Artificial Intelligence (AI) engine to generate at least one suggested code for one or more portions of the first clinical information; wherein the multi-stage AI engine comprises: a first module configured to detect whether the first clinical information includes any information associated with a second patient or whether the record contains second clinical information associated with a second patient; a second module configured to partition the first clinical information based on encounter; a third module configured to identify the one or more portions of the first clinical information; or a fourth module configured to identify content highlights within the one or more portions of the first clinical information and associate the content highlights with candidate codes, respectively.

Abstract: The present application provides a delay clock circuit, a signal transmission device and a method for determining delay, and relates to the field of circuit technologies. The delay clock circuit includes: a self-activation module, including a first inverter and a delay circuit, and used for generating a self-activation clock signal, where the first inverter is connected to an input end of the delay circuit and an output end of the delay circuit respectively; a first counter, connected to the self-activation module, and used for starting to work under a drive of the self-activation clock signal and a start counting signal and stopping working under a drive of a stop counting signal to obtain a first counting result within a preset duration; and a count processing module, connected to the first counter, and used for obtaining a delay of the delay circuit based on the preset duration and the first counting result.

Abstract: A tensegrity offshore wind power generation support structure is provided, relating to the technical field of offshore wind power. The support structure includes inclined columns, prestressed cables, a rigid support, a floating foundation and anchoring systems. A stable self-balancing space supporting structure is formed by the inclined columns and the cables; the inclined columns inclines outwards, upper parts of the inclined columns are connected with the prestressed cables; the bottom ends of the inclined columns are connected with the floating foundation; the middle parts of the inclined columns are connected with the rigid support; and the floating foundation is fixed with a seabed through the anchoring systems. According to the support structure, a tower in the traditional design is not needed, and all the cables are ensured to be in a tension state through the support of the inclined columns.

Abstract: Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.

Abstract: Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.

Abstract: Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: Apparatus and method for loading an application program view including obtaining view information of an application program, where the view information includes layout manner information of a view element, in a display interface, of an application program view, dimension information of the view element, and coordinate information of the view element in the display interface, performing serialization processing on the view information to obtain a byte stream used to display the application program view, and saving the byte stream in a non-volatile storage medium, so as to load the application program view according to the saved byte stream when the application program view is reloaded.

Abstract: Scaffold RNAs are provided. Compositions and methods are also provided for making and using scaffold RNAs.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.

Abstract: The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.